Template:Verapamil: Difference between revisions

Latest revision as of 00:11, 5 March 2014

Verapamil
CALAN tablet^® FDA Package Insert
Indications and Usage
Dosage and Administration
Dosage Forms and Strengths
Contraindications
Warnings and Precautions
Adverse Reactions
Drug Interactions
Use in Specific Populations
Overdosage
Description
Clinical Pharmacology
Nonclinical Toxicology
Clinical Studies
How Supplied/Storage and Handling
Patient Counseling Information
Labels and Packages
CALAN SR tablet extended release^® FDA Package Insert
Indications and Usage
Dosage and Administration
Dosage Forms and Strengths
Contraindications
Warnings
Precautions
Adverse Reactions
Drug Interactions
Use in Specific Populations
Overdosage
Description
Clinical Pharmacology
Nonclinical Toxicology
How Supplied/Storage and Handling
Labels and Packages
VERAPAMIL HYDROCHLORIDE injection^® FDA Package Insert
Indications and Usage
Dosage and Administration
Dosage Forms and Strengths
Contraindications
Warnings
Precautions
Adverse Reactions
Drug Interactions
Use in Specific Populations
Overdosage
Description
Clinical Pharmacology
Nonclinical Toxicology
How Supplied/Storage and Handling
Patient Counseling Information
Labels and Packages
Clinical Trials on Verapamil
ClinicalTrials.gov

@@ Line 63: / Line 63: @@
 |-
 ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Verapamil hydrochloride tablet extended release nonclinical toxicology|Nonclinical Toxicology]]
-|-
-! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Verapamil hydrochloride tablet extended release clinical studies|Clinical Studies]]
 |-
 ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Verapamil hydrochloride tablet extended release how supplied storage and handling|How Supplied/Storage and Handling]]
-|-
-! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Verapamil hydrochloride tablet extended release patient counseling information|Patient Counseling Information]]
 |-
 ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Verapamil hydrochloride tablet extended release labels and packages|Labels and Packages]]
@@ Line 99: / Line 95: @@
 |-
 ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Verapamil Hydrochloride injection nonclinical toxicology|Nonclinical Toxicology]]
-|-
-! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Verapamil hydrochloride injection clinical studies|Clinical Studies]]
 |-
 ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Verapamil hydrochloride injection how supplied storage and handling|How Supplied/Storage and Handling]]